SOX10 (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "SOX10" in French language version.

refsWebsite
Global rank French rank
4th place
12th place
2nd place
3rd place
1,626th place
2,018th place
low place
low place

doi.org

dx.doi.org

  • « SOX10 mutations in patients with Waardenburg-Hirschsprung disease », Nature Genetics, vol. 18, no 2,‎ , p. 171–3 (PMID 9462749, DOI 10.1038/ng0298-171)
  • « A molecular analysis of the yemenite deaf-blind hypopigmentation syndrome: SOX10 dysfunction causes different neurocristopathies », Human Molecular Genetics, vol. 8, no 9,‎ , p. 1785–9 (PMID 10441344, DOI 10.1093/hmg/8.9.1785)
  • « A tissue-restricted cAMP transcriptional response: SOX10 modulates alpha-melanocyte-stimulating hormone-triggered expression of microphthalmia-associated transcription factor in melanocytes », The Journal of Biological Chemistry, vol. 278, no 46,‎ , p. 45224–30 (PMID 12944398, DOI 10.1074/jbc.M309036200)
  • « Novel MITF targets identified using a two-step DNA microarray strategy », Pigment Cell & Melanoma Research, vol. 21, no 6,‎ , p. 665–76 (PMID 19067971, DOI 10.1111/j.1755-148X.2008.00505.x)
  • « Exome sequencing reveals the likely involvement of SOX10 in uveal melanoma », Optometry and Vision Science, vol. 91, no 7,‎ , e185–92 (PMID 24927141, DOI 10.1097/OPX.0000000000000309)
  • « Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3 », Hum. Genet., vol. 107, no 1,‎ , p. 1–6 (PMID 10982026, DOI 10.1007/s004390000328)
  • « Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome », Hum. Mol. Genet., vol. 9, no 13,‎ , p. 1907–17 (PMID 10942418, DOI 10.1093/hmg/9.13.1907)
  • « Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer », Hum. Mol. Genet., vol. 12, no 8,‎ , p. 937–45 (PMID 12668617, DOI 10.1093/hmg/ddg107)
  • « Melanocyte-specific expression of dopachrome tautomerase is dependent on synergistic gene activation by the Sox10 and Mitf transcription factors », FEBS Letters, vol. 556, nos 1–3,‎ , p. 236–44 (PMID 14706856, DOI 10.1016/s0014-5793(03)01446-7)
  • « Olig1 and Sox10 Interact Synergistically to Drive Myelin Basic Protein Transcription in Oligodendrocytes », The Journal of Neuroscience, vol. 27, no 52,‎ , p. 14375–82 (PMID 18160645, DOI 10.1523/jneurosci.4456-07.2007)
  • « Neuropathy-Associated Egr2 Mutants Disrupt Cooperative Activation of Myelin Protein Zero by Egr2 and Sox10 », Mol. Cell. Biol., vol. 27, no 9,‎ , p. 3521–29 (PMID 17325040, PMCID 1899967, DOI 10.1128/mcb.01689-06)
  • « The role of SOX10 during enteric nervous system development », Dev. Biol., vol. 382, no 1,‎ , p. 330–43 (PMID 23644063, DOI 10.1016/j.ydbio.2013.04.024)
  • « The high-mobility group transcription factor Sox10 interacts with the N-myc-interacting protein Nmi », J. Mol. Biol., vol. 353, no 5,‎ , p. 1033–42 (PMID 16214168, DOI 10.1016/j.jmb.2005.09.013)

ensembl.org

May2017.archive.ensembl.org

nih.gov

ncbi.nlm.nih.gov

  • « Publications PubMed pour l'Homme », sur National Center for Biotechnology Information, U.S. National Library of Medicine
  • « Publications PubMed pour la Souris », sur National Center for Biotechnology Information, U.S. National Library of Medicine
  • « SOX10 mutations in patients with Waardenburg-Hirschsprung disease », Nature Genetics, vol. 18, no 2,‎ , p. 171–3 (PMID 9462749, DOI 10.1038/ng0298-171)
  • « A molecular analysis of the yemenite deaf-blind hypopigmentation syndrome: SOX10 dysfunction causes different neurocristopathies », Human Molecular Genetics, vol. 8, no 9,‎ , p. 1785–9 (PMID 10441344, DOI 10.1093/hmg/8.9.1785)
  • « A tissue-restricted cAMP transcriptional response: SOX10 modulates alpha-melanocyte-stimulating hormone-triggered expression of microphthalmia-associated transcription factor in melanocytes », The Journal of Biological Chemistry, vol. 278, no 46,‎ , p. 45224–30 (PMID 12944398, DOI 10.1074/jbc.M309036200)
  • « Entrez Gene: SOX10 SRY (sex determining region Y)-box 10 »
  • « Novel MITF targets identified using a two-step DNA microarray strategy », Pigment Cell & Melanoma Research, vol. 21, no 6,‎ , p. 665–76 (PMID 19067971, DOI 10.1111/j.1755-148X.2008.00505.x)
  • « Exome sequencing reveals the likely involvement of SOX10 in uveal melanoma », Optometry and Vision Science, vol. 91, no 7,‎ , e185–92 (PMID 24927141, DOI 10.1097/OPX.0000000000000309)
  • « Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3 », Hum. Genet., vol. 107, no 1,‎ , p. 1–6 (PMID 10982026, DOI 10.1007/s004390000328)
  • « Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome », Hum. Mol. Genet., vol. 9, no 13,‎ , p. 1907–17 (PMID 10942418, DOI 10.1093/hmg/9.13.1907)
  • « Sox10 and Pax3 physically interact to mediate activation of a conserved c-RET enhancer », Hum. Mol. Genet., vol. 12, no 8,‎ , p. 937–45 (PMID 12668617, DOI 10.1093/hmg/ddg107)
  • « Melanocyte-specific expression of dopachrome tautomerase is dependent on synergistic gene activation by the Sox10 and Mitf transcription factors », FEBS Letters, vol. 556, nos 1–3,‎ , p. 236–44 (PMID 14706856, DOI 10.1016/s0014-5793(03)01446-7)
  • « Olig1 and Sox10 Interact Synergistically to Drive Myelin Basic Protein Transcription in Oligodendrocytes », The Journal of Neuroscience, vol. 27, no 52,‎ , p. 14375–82 (PMID 18160645, DOI 10.1523/jneurosci.4456-07.2007)
  • « Neuropathy-Associated Egr2 Mutants Disrupt Cooperative Activation of Myelin Protein Zero by Egr2 and Sox10 », Mol. Cell. Biol., vol. 27, no 9,‎ , p. 3521–29 (PMID 17325040, PMCID 1899967, DOI 10.1128/mcb.01689-06)
  • « The role of SOX10 during enteric nervous system development », Dev. Biol., vol. 382, no 1,‎ , p. 330–43 (PMID 23644063, DOI 10.1016/j.ydbio.2013.04.024)
  • « The high-mobility group transcription factor Sox10 interacts with the N-myc-interacting protein Nmi », J. Mol. Biol., vol. 353, no 5,‎ , p. 1033–42 (PMID 16214168, DOI 10.1016/j.jmb.2005.09.013)

pathologyoutlines.com

  • Nat Pernick, « Stains - SOX10 », Pathology Outlines Topic Completed: 1 February 2014. Revised: 20 September 2019